FR2905380B1 - Procede de production de cellules de langerhans et/ou de cellules de dentritiques interstitielles/dermiques a partir de monocytes cd14+ - Google Patents

Procede de production de cellules de langerhans et/ou de cellules de dentritiques interstitielles/dermiques a partir de monocytes cd14+

Info

Publication number
FR2905380B1
FR2905380B1 FR0653567A FR0653567A FR2905380B1 FR 2905380 B1 FR2905380 B1 FR 2905380B1 FR 0653567 A FR0653567 A FR 0653567A FR 0653567 A FR0653567 A FR 0653567A FR 2905380 B1 FR2905380 B1 FR 2905380B1
Authority
FR
France
Prior art keywords
cells
dermic
monocytes
interstitial
dentritic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0653567A
Other languages
English (en)
Other versions
FR2905380A1 (fr
Inventor
Nicolas Bechetoille
Valerie Andre
Isabelle Orly
Eric Perrier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Beauty Care Solutions France SAS
Original Assignee
Engelhard Lyon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0653567A priority Critical patent/FR2905380B1/fr
Application filed by Engelhard Lyon SA filed Critical Engelhard Lyon SA
Priority to BRPI0716107-7A2A priority patent/BRPI0716107A2/pt
Priority to JP2009526123A priority patent/JP2010502175A/ja
Priority to KR1020097006847A priority patent/KR20090049620A/ko
Priority to PCT/EP2007/059165 priority patent/WO2008028882A1/fr
Priority to EP07803152A priority patent/EP2064318A1/fr
Priority to CA002662231A priority patent/CA2662231A1/fr
Publication of FR2905380A1 publication Critical patent/FR2905380A1/fr
Application granted granted Critical
Publication of FR2905380B1 publication Critical patent/FR2905380B1/fr
Priority to US12/851,592 priority patent/US20100297765A1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698—Skin equivalents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/097—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells oral mucosa cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C12N2502/1121—Dendritic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C12N2502/1157—Monocytes, macrophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/24—Genital tract cells, non-germinal cells from gonads
    • C12N2502/243—Cells of the female genital tract, non-germinal ovarian cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
FR0653567A 2006-09-04 2006-09-04 Procede de production de cellules de langerhans et/ou de cellules de dentritiques interstitielles/dermiques a partir de monocytes cd14+ Expired - Fee Related FR2905380B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR0653567A FR2905380B1 (fr) 2006-09-04 2006-09-04 Procede de production de cellules de langerhans et/ou de cellules de dentritiques interstitielles/dermiques a partir de monocytes cd14+
JP2009526123A JP2010502175A (ja) 2006-09-04 2007-09-03 Ｃｄ１４＋単球からランゲルハンス細胞及び／又は真皮／間質性樹状細胞を製造する方法
KR1020097006847A KR20090049620A (ko) 2006-09-04 2007-09-03 Ｃｄ14＋ 단구로부터 랑게르한스 세포 및/또는 진피/간질성 수지상 세포를 생성시키는 방법
PCT/EP2007/059165 WO2008028882A1 (fr) 2006-09-04 2007-09-03 Procédé de production de cellules de langerhans et/ou des cellules dendritiques dermiques/interstitielles à partir de monocytes cd14+
BRPI0716107-7A2A BRPI0716107A2 (pt) 2006-09-04 2007-09-03 mÉtodos para preparar cÉlulas de langerhans ou cÉlulas dendrÍticas e para diferenciar monàcitos, modelo de cÉlulas, monàcitos cd14+ congelados, uso de pelo menos um modelo de cÉlula e/ou de pelo menos um modelo de tecido, e, mÉtodos para produzir um modelo de tecido, e uma pele reconstruÍda ou uma mucosa reconstruÍda
EP07803152A EP2064318A1 (fr) 2006-09-04 2007-09-03 Procédé de production de cellules de langerhans et/ou des cellules dendritiques dermiques/interstitielles à partir de monocytes cd14+
CA002662231A CA2662231A1 (fr) 2006-09-04 2007-09-03 Procede de production de cellules de langerhans et/ou des cellules dendritiques dermiques/interstitielles a partir de monocytes cd14+
US12/851,592 US20100297765A1 (en) 2006-09-04 2010-08-06 Method for producing langerhans cells or interstitial dendritic cells or both from cd14+ monocytes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0653567A FR2905380B1 (fr) 2006-09-04 2006-09-04 Procede de production de cellules de langerhans et/ou de cellules de dentritiques interstitielles/dermiques a partir de monocytes cd14+

Publications (2)

Publication Number Publication Date
FR2905380A1 FR2905380A1 (fr) 2008-03-07
FR2905380B1 true FR2905380B1 (fr) 2008-12-05

Family

ID=37781699

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0653567A Expired - Fee Related FR2905380B1 (fr) 2006-09-04 2006-09-04 Procede de production de cellules de langerhans et/ou de cellules de dentritiques interstitielles/dermiques a partir de monocytes cd14+

Country Status (7)

Country Link
EP (1) EP2064318A1 (fr)
JP (1) JP2010502175A (fr)
KR (1) KR20090049620A (fr)
BR (1) BRPI0716107A2 (fr)
CA (1) CA2662231A1 (fr)
FR (1) FR2905380B1 (fr)
WO (1) WO2008028882A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120171194A1 (en) * 2009-03-17 2012-07-05 Colin Tso Method of Cell Differentiation and Uses Therefor in Screening, Diagnosis and Therapy
GB201700138D0 (en) 2017-01-05 2017-02-22 Senzagen Ab Analytical methods and arrays for use in the same
JP7522042B2 (ja) * 2018-11-30 2024-07-24 株式会社 資生堂 色素沈着皮膚モデルおよびその製造方法、ならびに皮膚の色素沈着を治療または予防するための因子の評価方法
CN114258428A (zh) * 2019-09-17 2022-03-29 凸版印刷株式会社 细胞结构体及其制造方法
FR3132146A1 (fr) * 2022-01-27 2023-07-28 Genoskin Modèle humain ex vivo destiné à l’évaluation du potentiel vaccinal d’une composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2743817B1 (fr) * 1996-01-23 1998-03-13 Oreal Equivalent de peau comprenant des cellules de langerhans
US7566568B2 (en) * 2001-04-27 2009-07-28 Istituto Superiore Di Sanita Method for generating highly active human dendritic cells from peripheral blood mononuclear cells
FR2833271B1 (fr) * 2001-12-10 2004-09-17 Coletica Production de cellules dendritiques in vitro a partir de monocytes cd14+, pour notamment la realisation de modeles cellulaires et/ou tissulaires en suspension, en monocouches et tridimentionnels; utilisation de ces modeles
EP1688483A4 (fr) * 2003-07-22 2007-09-12 Kirin Brewery Procede de preparation de cellules de langerhans a partir de cellules positives cd14 qui sont des cellules mononucleaires du sang humain a l'aide d'un ligand notch delta-1, gm-csf et tgf-beta

Also Published As

Publication number Publication date
BRPI0716107A2 (pt) 2013-09-24
KR20090049620A (ko) 2009-05-18
FR2905380A1 (fr) 2008-03-07
EP2064318A1 (fr) 2009-06-03
JP2010502175A (ja) 2010-01-28
WO2008028882A1 (fr) 2008-03-13
CA2662231A1 (fr) 2008-03-13

Similar Documents

Publication Publication Date Title
EP2090331A4 (fr) Matrice à micro-aiguilles et son procédé de production
IL228362A (en) A method for preparing sugars by biological mass processing
EP2033981A4 (fr) Copolymère de polycarbonate et son procédé de production
BRPI0916498A2 (pt) Método de produção de biomassa enriquecida com carboidratos e método de fragmentação simultânea e extração seletiva de lignina
EP2343379A4 (fr) Procédé de fabrication d'un saccharide et procédé de fabrication d'éthanol
EP2233129A4 (fr) Comprimé se désintégrant dans la cavité buccale et son procédé de fabrication
EP2090609A4 (fr) Procédé de fabrication d'une solution d'acide polyamide et solution d'acide polyamique
EP2368544A4 (fr) Comprimé à délitement oral rapide, et procédé pour produire celui-ci
EP2213678A4 (fr) Procédés de fabrication de lignine solubilisée, de matière première saccharidique et de matière première monosaccharidique et lignine solubilisée
EP2011860A4 (fr) Bactérie capable de produire une substance purine et procédé de production d'une substance purine
EP2039783A4 (fr) Procédé de production d'un polysaccharide et/ou d'un monosaccharide par l'hydrolyse d'un autre polysaccharide
SI1991690T1 (sl) Postopek za pridobivanje sializiranih oligosaharidov
EP1999134A4 (fr) Procede de production d'alcools de sucre anhydres
EP2223951A4 (fr) Procédé de production de polycarbonate et moulages en polycarbonate
EP1992685A4 (fr) Procédé innovant de culture de cellules et procédés de production et de récolte de masses cellulaires utilisant ledit procédé
EP2060665A4 (fr) Fibre d'acide polylactique et procédé de fabrication
HK1158990A1 (en) Tablet quickly disintegrating in the oral cavity and method for producing the same
HK1135713A1 (en) Process for producing polylactic acid block copolymer
EP2130909A4 (fr) Procédé de production de dent et dent produite par le procédé
EP2011861A4 (fr) Bactérie capable de produire une substance purine et procédé de production d'une substance purine
EP2103576A4 (fr) Système de fabrication de ciment et procédé de fabrication
EP2062599A4 (fr) Comprimé se désintegrant oralement et procédé de fabrication de celui-ci
EP2115460A4 (fr) Nouveaux glucides issus de cellules humaines et methodes d'analyse et de modification
EP1894885A4 (fr) Réacteur pour la production de chlore et procédé de production de chlore
FR2905380B1 (fr) Procede de production de cellules de langerhans et/ou de cellules de dentritiques interstitielles/dermiques a partir de monocytes cd14+

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 11

ST Notification of lapse

Effective date: 20180531